secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aveanna Healthcare Holdings, Inc. (AVAH)
CIK:        0001832332
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0000950170-22-023858
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aveanna Q3 revenue $443M (+7.7% YoY), adj EBITDA $24.7M vs $45.8M YoY
---------------------------------------------------------------------

- Revenue $443.0M, up 7.7% YoY; gross margin 30.4% vs 34.0% YoY.
- Adjusted net loss per diluted share $(0.03) vs adjusted net income $0.11 in prior year.
- Adjusted EBITDA $24.7M (5.6% of revenue) versus $45.8M (11.1% of revenue) in Q3 2021.
- CEO cites difficult labor environment and HHH system conversion impact; expects return to normal into 2023.
- Liquidity: $63.7M cash, $182.4M revolver available, $140M DDTL for acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832332/000095017022023858/0000950170-22-023858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832332/000095017022023858/avah-20221109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-023858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer